	US 12,083,209 B2
	Oral care composition
Kana Hashimoto, Mount Prospect, IL (US); and Toru Saito, Buffalo Grove, IL (US)
Assigned to SUNSTAR AMERICAS, INC., Schaumburg, IL (US)
Filed by SUNSTAR AMERICAS, INC., Schaumburg, IL (US)
Filed on Feb. 12, 2021, as Appl. No. 17/174,698.
Claims priority of provisional application 62/978,098, filed on Feb. 18, 2020.
Prior Publication US 2021/0251870 A1, Aug. 19, 2021
Int. Cl. A61K 8/49 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/92 (2006.01); A61Q 11/00 (2006.01)

CPC A61K 8/4926 (2013.01) [A61K 8/442 (2013.01); A61K 8/731 (2013.01); A61K 8/922 (2013.01); A61Q 11/00 (2013.01); A61K 2800/30 (2013.01); A61K 2800/48 (2013.01)]

18 Claims

1. A liquid oral composition comprising:

0.01% by weight to 0.4% by weight of an antimicrobial agent that is cetylpyridinium chloride (CPC);

0.005% by weight to 0.05% by weight of a cationic surfactant that is 2-pyrrolidone-5-carboxylic acid (PCA) ethyl cocoyl arginate;

0.05% by weight to 2% by weight of an emulsifier that is a poly(oxyethylene) hydrogenated castor oil that has an average molar number of ethylene oxide units added of 35 to 100 moles; and

0.1% by weight to 0.3% by weight of a thickener that is a non-ionic polymer.